JP2025501775A5 - - Google Patents
Info
- Publication number
- JP2025501775A5 JP2025501775A5 JP2024539010A JP2024539010A JP2025501775A5 JP 2025501775 A5 JP2025501775 A5 JP 2025501775A5 JP 2024539010 A JP2024539010 A JP 2024539010A JP 2024539010 A JP2024539010 A JP 2024539010A JP 2025501775 A5 JP2025501775 A5 JP 2025501775A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- amino acid
- substantially similar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163266008P | 2021-12-27 | 2021-12-27 | |
| US63/266,008 | 2021-12-27 | ||
| PCT/US2022/082428 WO2023129928A2 (en) | 2021-12-27 | 2022-12-27 | Antibody specific to spike protein of sars-cov-2 and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501775A JP2025501775A (ja) | 2025-01-23 |
| JP2025501775A5 true JP2025501775A5 (enExample) | 2025-02-06 |
Family
ID=87000251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024539010A Pending JP2025501775A (ja) | 2021-12-27 | 2022-12-27 | ＳＡＲＳ－ＣｏＶ－２のスパイクタンパク質に対して特異的な抗体及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230279080A1 (enExample) |
| EP (1) | EP4457243A4 (enExample) |
| JP (1) | JP2025501775A (enExample) |
| CN (1) | CN120787235A (enExample) |
| TW (1) | TW202342511A (enExample) |
| WO (1) | WO2023129928A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180128545A1 (en) | 2016-11-08 | 2018-05-10 | Berry Metal Company | Modular furnace cooling wall |
| CA3131096A1 (en) | 2019-04-05 | 2020-10-08 | Chi-Huey Wong | Sialidase-resistant saccharide and method of making and using the same |
| CA3182526A1 (en) | 2020-05-08 | 2021-11-11 | Academia Sinica | Chimeric influenza vaccines |
| WO2022221837A2 (en) | 2021-04-12 | 2022-10-20 | Academia Sinica | Improved coronavirus vaccine |
| TW202334429A (zh) | 2021-10-01 | 2023-09-01 | 中央研究院 | Sars-cov-2棘蛋白特異性抗體及其用途 |
| NZ825394A (en) | 2023-04-08 | 2026-03-27 | Rock Biomedical Inc | Methods and compositions for dendritic cell targeting nano-delivery |
| CA3268566A1 (en) | 2023-04-08 | 2024-10-17 | Rock Biomedical Inc. | METHODS AND COMPOSITIONS FOR TARGETED DISTRIBUTION BY POLYMERSOMES |
| CN121175414A (zh) | 2023-05-17 | 2025-12-19 | 磐石医药生技股份有限公司 | Mgat1缺乏细胞及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2014681A1 (en) * | 2007-07-12 | 2009-01-14 | Pierre Fabre Medicament | Novel antibodies inhibiting c-met dimerization, and uses thereof |
| US20110250203A1 (en) * | 2008-08-29 | 2011-10-13 | Symphogen A/S | Anti-cd5 antibodies |
| EP3347048B1 (en) * | 2015-09-09 | 2020-04-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antibodies having specificity to nectin-4 and uses thereof |
| US20190194345A1 (en) * | 2015-10-05 | 2019-06-27 | University Of Virginia Patent Foundation | Anti-sas1b antibodies, associated methods of use, and compositions and methods for detecting and treating cancer |
| US11370842B2 (en) * | 2017-08-01 | 2022-06-28 | City Of Hope | Anti-IL1RAP antibodies |
| CN110713537B (zh) * | 2018-07-13 | 2023-04-21 | 江苏怀瑜药业有限公司 | 一种sema4d抗体及其制备方法和应用 |
| CR20220552A (es) * | 2020-04-02 | 2023-01-17 | Regeneron Pharma | Anticuerpos contra glicoproteína de espícula anti-sars-cov-2 y fragmentos de unión al antígeno |
-
2022
- 2022-12-27 US US18/146,873 patent/US20230279080A1/en active Pending
- 2022-12-27 WO PCT/US2022/082428 patent/WO2023129928A2/en not_active Ceased
- 2022-12-27 EP EP22917516.1A patent/EP4457243A4/en active Pending
- 2022-12-27 JP JP2024539010A patent/JP2025501775A/ja active Pending
- 2022-12-27 TW TW111150166A patent/TW202342511A/zh unknown
- 2022-12-27 CN CN202280086089.0A patent/CN120787235A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024109678A5 (enExample) | ||
| JP2021526022A5 (enExample) | ||
| JP2020152735A5 (enExample) | ||
| JP2022075818A5 (enExample) | ||
| JP2021521843A5 (enExample) | ||
| RU2011105062A (ru) | Нейтрализующие антитела против вируса гриппа а и их использование | |
| RU2588467C3 (ru) | Стабильные и растворимые антитела, ингибирующие vegf | |
| RU2012112829A (ru) | Анти-gitr-антитела | |
| JP2010516229A5 (enExample) | ||
| RU2016129274A (ru) | Канинизированные мышиные антитела к человеческому pd-1 | |
| JP2011528902A5 (enExample) | ||
| JP2015534982A5 (enExample) | ||
| JP2023093753A5 (enExample) | ||
| US20200347130A1 (en) | CD96 Antibody, Antigen-Binding Fragment and Pharmaceutical use Thereof | |
| JP2020501598A5 (enExample) | ||
| JP2024542194A5 (enExample) | ||
| RU2012103212A (ru) | Tlr3 связывающие агенты | |
| JP2020522280A5 (enExample) | ||
| JP2024538148A5 (enExample) | ||
| JP2021501579A5 (enExample) | ||
| JP2020522281A5 (enExample) | ||
| JP2024540148A5 (enExample) | ||
| JP2025508066A5 (enExample) | ||
| JP2023182689A5 (enExample) | ||
| JPWO2022044573A5 (enExample) |